May 2025· Journal of Chemical Information and Modeling· Vol 65, pp. 5481-5494· 2 citations· 58 references
MedicineComputer Science
TL;DR
This study established a unified model (NRIGN) based on the deep graphic architecture to discriminate agonists and antagonists targeting 26 successful or in-clinical-trial NR targets and achieves an excellent prediction accuracy and is robust enough to be applied in various real-world scenarios.
Abstract
To fulfill functions for differentially regulating the downstream signaling pathways, functional ligands (i.e., agonists or antagonists) targeting nuclear receptors (NRs) are designed to stabilize different conformations (active or inactive) of the proteins. However, in practical applications, it is usually difficult to determine the molecular category of an NR ligand because these molecules all bind in the same location of an NR protein, namely, the ligand-binding pocket (LBP). Considering that ligands with different properties (agonists or antagonists) prefer to bind with differential conformations of NRs, it is possible to identify the molecular type of a given ligand through the differential binding environment (active or inactive conformations) of the protein-ligand interaction. Therefore, in this study, we established a unified model (NRIGN) based on the deep graphic architecture to discriminate agonists and antagonists targeting 26 successful or in-clinical-trial NR targets. Our result shows that NRIGN achieves an excellent prediction accuracy (ACC >0.95) and is robust enough to be applied in various real-world scenarios, such as predicting the molecular type of ligands in crystallized NR structures, ligands with multiple NR activities, and ligands with their types altered by target mutations. The proposed model is expected to promote rational design of drugs targeting NR proteins.
This work explores structure-based strategies to identify small-molecule agonists of neurotensin (NTS) receptors, leading to the discovery of potent agonists with in vivo antinociceptive effects and to insights into the molecular basis of receptor activation.
Nicolas Panel, D. D. Vo, Harald Hübner et al.· Nature Communications· 0 citations
This study maps the landscape of GPCR classification and function by translating the majority of the GPCR structures into structure graphs and analyzing over 2 million structural contacts to capture key aspects of the structural communication within the GPCR superfamily with implications in drug discovery.
Sara Gentile, Angelo Felline, Sara Mazzali et al.· JACS Au· 0 citations
A dynamics-aware molecular descriptor, LDR, is developed that can be a key factor in quantifying partial agonism arising from small-molecule ligand drift away from the primary orthosteric site and it is found that adding constraints on pose diversity and allowing receptor flexibility can improve LDR’s ability to distin...
Ying-Ting Lin, Yung-Ting Shih· Journal of Chemical Informat...· 0 citations
A versatile “deep receptor scanning” platform is introduced that can be used to experimentally characterize 766 human GPCRs and 174 known GPCR splice variants in parallel and show that many highly-expressed receptors exhibit systematic differences in hydrophobicity and secondary structure.
A. Tedman, Muskan Goel, Sohan S. Shah et al.· Nature Communications· 0 citations
A comprehensive assessment based on systematic benchmarking using a diverse set of class A G-protein-coupled receptors and different approaches to represent protein–ligand demonstrates that the combined approach overall improves the efficacy bias of selected ligands as compared to docking alone.
Luca Chiesa, G. Bret, Severine Schneider et al.· Journal of Chemical Informat...· 0 citations
The convergence of docking, dynamics, and free-energy results prioritized PM2, PM3, and PM4 as promising MAP3K8 hit candidates, which require further experimental validation and lead optimization.
M. Islam, A. Iqbal, M. A. Ali et al.· Molecular diversity· 0 citations
Jennifer Neville did not want to go into computer science—but that’s exactly where she landed. Neville discusses the starts and stops that led to her professional sweet spot and her work identifying “surprising failures” making it hard for AI to handle complexity. The post What AI gets wrong and what failure teaches us appeared first on Microsoft Research.
A new computational approach reveals how cells communicate to assemble into tissues. This could accelerate stem cell engineering, improve disease models, and inform therapies.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.